We are live on ! Find out more
GIM

Granahan Investment Management Portfolio holdings

AUM $2.07B
1-Year Est. Return 56.45%
This Fund
S&P 500
This Quarter Est. Return
-19.73%
1 Year Est. Return
+56.45%
3 Year Est. Return
+154.74%
5 Year Est. Return
+144.99%
10 Year Est. Return
+2,522.93%
AUM
$1.41B
AUM Growth
-$431M
Cap. Flow
-$49.9M
Cap. Flow %
-3.54%
Top 10 Hldgs %
24.85%
Holding
216
New
15
Increased
64
Reduced
101
Closed
23

Sector Composition

Rank Sector Weight
1 Technology 34.67%
2 Healthcare 21.97%
3 Industrials 15.66%
4 Consumer Discretionary 8.08%
5 Consumer Staples 4.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PODD icon
101
Insulet
PODD
$9.78B
$3.34M 0.24%
42,059
-6,825
-14% -$578K
QLYS icon
102
Qualys
QLYS
$6.38B
$3.31M 0.23%
44,350
-2,550
-5% -$192K
NTNX icon
103
Nutanix
NTNX
$16.9B
$3.25M 0.23%
78,088
+700
+0.9% +$28.9K
WNS
104
DELISTED
WNS Holdings
WNS
$3.19M 0.23%
77,409
COLL icon
105
Collegium Pharmaceutical
COLL
$931M
$3.17M 0.22%
184,633
-12,404
-6% -$212K
AUTL
106
Autolus Therapeutics
AUTL
$559M
$3.17M 0.22%
96,450
-4,312
-4% -$142K
HIVE
107
DELISTED
Aerohive Networks
HIVE
$3.15M 0.22%
967,155
-5,290
-0.5% -$19.9K
PRFT
108
DELISTED
Perficient Inc
PRFT
$3.07M 0.22%
137,782
MGNX icon
109
MacroGenics
MGNX
$254M
$3.05M 0.22%
240,488
-6,428
-3% -$108K
DBX icon
110
Dropbox
DBX
$7.99B
$2.99M 0.21%
+146,342
New +$3.37M
CLDR
111
DELISTED
Cloudera, Inc.
CLDR
$2.96M 0.21%
267,269
+120,724
+82% +$1.61M
IVC
112
DELISTED
Invacare Corporation
IVC
$2.92M 0.21%
677,984
-15,907
-2% -$141K
PTC icon
113
PTC
PTC
$16B
$2.87M 0.2%
34,645
PRLB icon
114
Protolabs
PRLB
$2.13B
$2.63M 0.19%
23,300
TRTN
115
DELISTED
Triton International Limited
TRTN
$2.59M 0.18%
83,503
-78,237
-48% -$2.52M
ULTI
116
DELISTED
Ultimate Software Group Inc
ULTI
$2.59M 0.18%
10,587
+182
+2% +$48.2K
FNSR
117
DELISTED
Finisar Corp
FNSR
$2.49M 0.18%
115,411
+6,000
+5% +$119K
MINI
118
DELISTED
Mobile Mini Inc
MINI
$2.47M 0.18%
77,920
-26,100
-25% -$1.01M
CTMX icon
119
CytomX Therapeutics
CTMX
$752M
$2.47M 0.17%
163,547
-3,541
-2% -$52.5K
ABMD
120
DELISTED
Abiomed Inc
ABMD
$2.43M 0.17%
+7,465
New +$2.59M
NXST icon
121
Nexstar Media Group
NXST
$5.93B
$2.41M 0.17%
30,607
-6,201
-17% -$491K
HTGM
122
DELISTED
HTG Molecular Diagnostics, Inc. Common Stock
HTGM
$2.35M 0.17%
5,135
-94
-2% -$58.3K
FENC icon
123
Fennec Pharmaceuticals
FENC
$391M
$2.33M 0.16%
364,933
+141,810
+64% +$991K
CTSO icon
124
Cytosorbents Corp
CTSO
$23.3M
$2.25M 0.16%
278,170
+90,870
+49% +$902K
INGN icon
125
Inogen
INGN
$164M
$2.25M 0.16%
+18,103
New +$2.98M

Similar funds

Granahan Investment Management's Q4 2018 Portfolio in Review

As of Q4 2018, Granahan Investment Management held 216 positions worth $1.41B, down 23% from $1.84B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Granahan Investment Management withdrew a net $49.9M in Q4 2018, closing 23 positions and reducing 101 holdings. Its most notable exit was SodaStream International Ltd, an estimated $42.2M position sold in full.

By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 33% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Granahan Investment Management opened a new position in JBT Marel worth $9.22M.

  • Granahan Investment Management's largest Q4 2018 buy was JBT Marel: 128,350 shares worth $9.22M.
  • Granahan Investment Management added most to Paylocity in Q4 2018, an estimated $13.6M increase.
  • Granahan Investment Management's biggest Q4 2018 reduction was Strategic Education, cutting an estimated $12.1M.
  • Granahan Investment Management fully exited SodaStream International Ltd in Q4 2018, selling an estimated $42.2M.
  • Granahan Investment Management's ten largest holdings make up 25% of its $1.41B portfolio in Q4 2018.
  • Granahan Investment Management opened 15 new positions and closed 23 in Q4 2018.
  • Granahan Investment Management's portfolio value fell 23% quarter-over-quarter to $1.41B.

Based on Granahan Investment Management's 13F filing for Q4 2018, filed 13 Feb 2019.